TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
MIRAPHARM AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
151
|
109
|
98 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
37
|
4,241
|
55 |
| EBITDA |
-11
|
25
|
53 |
| Total assets |
2,081
|
4,347
|
244 |
| Current assets |
1,746
|
4,035
|
124 |
| Current liabilities |
53
|
18
|
25 |
| Equity capital |
2,028
|
4,329
|
218 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
1
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
97.5%
|
99.6%
|
89.3% |
| Turnover per employee | 151 | ||
| Profit as a percentage of turnover |
24.5%
|
3890.8%
|
56.1% |
| Return on assets (ROA) |
1.8%
|
97.6%
|
22.5% |
| Current ratio |
3294.3%
|
22416.7%
|
496.0% |
| Return on equity (ROE) |
1.8%
|
98.0%
|
25.2% |
| Change turnover |
34
|
13
|
-11 |
| Change turnover % |
30%
|
14%
|
-10% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.